Cerebral blood flow alterations in migraine patients with and without aura: An arterial spin labeling study

Table 1 The demographic and clinical outcome of all patients

	MwA in the training sample (n = 32)	MwoA in the training sample (n = 56)	p-value^a	Patients in the training sample (n = 88)	Patients in the testing sample (n = 30)	p-value^a
Age (years)	35.4 ± 12.1	37.0 ± 8.9	0.48	36.4 ± 10.1	37.2 ± 8.6	0.70
Gender (M/F)	7/25	11/45	0.80^b	18/70	7/23	0.74^b
Education (years)	13.4 ± 3.7	14.0 ± 3.2	0.48	13.8 ± 3.4	15.5 ± 1.6	< 0.01
Duration (years)	11.8 ± 8.7	14.4 ± 8.8	0.19	13.4 ± 8.8	13.1 ± 8.9	0.87
Frequency (days per month)	4.1 ± 4.0	5.4 ± 6.6	0.35	4.8 ± 5.7	5.2 ± 5.6	0.74
Headache severity score	6.0 ± 1.4	4.3 ± 1.2	< 0.01	5.0 ± 1.5	4.6 ± 1.0	0.18
HIT-6	60.5 ± 7.7	59.6 ± 7.3	0.61	59.9 ± 7.4	61.4 ± 6.3	0.32
MIDAS	19.2 ± 20.0	17.5 ± 21.8	0.75	18.2 ± 20.9	17.2 ± 14.1	0.81
MoCA	25.8 ± 3.1	25.7 ± 3.2	0.97	25.7 ± 3.2	29.6 ± 0.8	< 0.01
SAS	52.4 ± 5.2	43.6 ± 7.0	< 0.01	46.8 ± 9.6	49.0 ± 13.5	0.33
SDS	47.2 ± 7.1	39.0 ± 6.0	< 0.01	42.0 ± 8.7	45.6 ± 12.0	0.08

HIT-6: Headache Impact Test-6, MIDAS: Migraine Disability Assessment Score, MoCA: Montreal Cognitive Assessment, MwA: migraine patients with aura, MwoA: migraine patients without aura, SAS: Self-Rating Anxiety Scale, SDS: Self-Rating Depression Scale
Values are represented as the mean ± standard deviation, except for the gender distribution
^aUnless otherwise indicated, p values were calculated with two-tailed t-tests
^bThe p values were obtained using chi-squared tests

ISSN: 1129-2377